15/12/2016 - 07:00 RNS
RNS Number: 8781R AIM 15 December 2016 NOTICE 15/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM CYPROTEX PLC At the request of the company trading on AIM for the under-mentioned securities has been cancelled from 15/12/2016 7:00am. ORDINARY SHARES OF 0.01 EACH, FULLY PAID (BP25RZ1)(GB00BP25R...
14/12/2016 - 16:03 RNS
RNS Number: 8766R Cyprotex PLC 14 December 2016 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART), DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY RESTRICTED JURISDICTION (INCLUDING THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA AND NEW ZE...
14/12/2016 - 07:30 RNS
RNS Number: 7400R AIM 14 December 2016 NOTICE 14/12/2016 7:30am TEMPORARY SUSPENSION OF TRADING ON AIM CYPROTEX PLC At the request of the company trading on AIM for the under-mentioned securities has been temporarily suspended from 14/12/2016 7:30am, pending an announcement. ORDINARY SHARES OF 0.01 EACH, FULLY PAID ...
13/12/2016 - 15:32 RNS
RNS Number: 7514R Cyprotex PLC 13 December 2016 Cyprotex PLC ("Cyprotex" or "the Company") Director Dealing Cyprotex PLC (AIM: CRX), a specialist Contract Research Organisation, announces that it was notified on 12 December 2016 that, on 8 December 2016, John Dootson, Chief Financial Officer, transferred 36,000 ordinary shares of 1p each in the Compa...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment